Skip to main content
. Author manuscript; available in PMC: 2008 Apr 28.
Published in final edited form as: Biol Psychiatry. 2007 Nov 5;63(7):642–649. doi: 10.1016/j.biopsych.2007.09.019

Figure 2.

Figure 2

Localized Deletion of BDNF in the CA1 and DG Subregions Does Not Alter Locomotor Activity. (A) Male mice injected into the CA1 with either AAV-Cre or AAV-GFP exhibited no significant difference in locomotor activity (ambulation), as assessed by a consecutive horizontal beam break, over a two-hour period in either 5 minute increments or over the entire two-hour period (see insert; AAV-GFP, n = 12; AAV-Cre, n = 11). (B) The male mice injected into the DG region with either AAV-Cre or AAV-GFP exhibited a similar level of locomotor activity during the testing period whether analyzed as 5 minute increments or total number of beam breaks over the entire two-hour period (see insert; AAV-GFP, n = 23; AAV-Cre, n = 24).